Some people who take Paxlovid could see symptoms reappear two to eight days after finishing the treatment and testing negative, the CDC said.
posted online in late April sequenced virus samples from a 71-year-old man who saw his illness rebound after finishing Paxlovid. The study, which is under review by a medical journal, found no indication that the man had developed resistance to the drug; instead, the authors suggested that symptoms may recur “before natural immunity is sufficient to fully clear” the virus.
Dr. Bob Wachter, chair of the University of California, San Francisco's Department of Medicine, chronicled the case of his wife, Katie Hafner.he wrote on Tuesday
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID-19 rebound reported after Pfizer’s pill Paxlovid, CDC saysA small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.
Baca lebih lajut »
Dr. Makary: CDC did not present 'scientific rationale' for COVID booster shots for kidsDr. Marty Makary assesses the Biden administration's process for recommending that children ages 5-11 get a COVID vaccine booster shot.
Baca lebih lajut »
Anyone can get monkeypox, but CDC warns LGBTQ community about 'greater chance' of exposure nowAnyone can get or spread monkeypox, but a 'notable fraction of cases' in the latest global outbreak are happening among gay and bisexual men, the US Centers for Disease Control and Prevention said Monday.
Baca lebih lajut »
Monkeypox cases may be mistaken for a sexual transmitted disease, CDC warnsSo far, scientists have recorded more than 250 confirmed or suspected monkeypox cases, mainly in Europe, and are trying to determine if and how the cases might be connected.
Baca lebih lajut »
US in process of releasing monkeypox vaccine from national stockpile for 'high-risk' people: CDCThe United States is responding to a request for the release of monkeypox vaccine from the nation's Strategic National Stockpile as a global outbreak of cases is under investigation.
Baca lebih lajut »
CDC investigating more monkeypox casesWhile more infections are likely in the U.S., health officials said Monday there is no evidence that the virus is spreading widely in the country.
Baca lebih lajut »